These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36034049)

  • 1. SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective.
    Elfiky AA; Ibrahim IM; Elgohary AM
    Int J Pept Res Ther; 2022; 28(5):146. PubMed ID: 36034049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
    Ibrahim IM; Elfiky AA; Elgohary AM
    Biochem Biophys Res Commun; 2021 Jul; 562():89-93. PubMed ID: 34049205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
    Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF
    Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis.
    Khater I; Nassar A
    Inform Med Unlocked; 2022; 29():100873. PubMed ID: 35136832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q.
    Ahamad S; Hema K; Ahmad S; Kumar V; Gupta D
    3 Biotech; 2022 Apr; 12(4):87. PubMed ID: 35265451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding.
    Hoter A; Naim HY
    Front Mol Biosci; 2022; 9():893843. PubMed ID: 35677879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids.
    Amin FG; Elfiky AA; Nassar AM
    J Biomol Struct Dyn; 2024; 42(2):1079-1087. PubMed ID: 37042960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots.
    Pramanik A; Sharma PC; Patibandla S; Gao Y; Ruppa-Kasani V; Goli J; Kumar A; Chatterjee A; Sinha SS; Bates JT; Bierdeman MA; Tandon R; Ray PC
    ACS Omega; 2022 Mar; 7(9):8150-8157. PubMed ID: 35252734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant.
    Antony P; Vijayan R
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective.
    Elshemey WM; Elfiky AA; Ibrahim IM; Elgohary AM
    Comput Biol Med; 2022 Jun; 145():105478. PubMed ID: 35421790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity.
    Neerukonda SN; Vassell R; Lusvarghi S; Wang R; Echegaray F; Bentley L; Eakin AE; Erlandson KJ; Katzelnick LC; Weiss CD; Wang W
    bioRxiv; 2021 Nov; ():. PubMed ID: 34790980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamic simulation suggests stronger interaction of Omicron-spike with ACE2 than wild but weaker than Delta SARS-CoV-2 can be blocked by engineered S1-RBD fraction.
    Santra D; Maiti S
    Struct Chem; 2022; 33(5):1755-1769. PubMed ID: 35966763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural-Dynamics and Binding Analysis of RBD from SARS-CoV-2 Variants of Concern (VOCs) and GRP78 Receptor Revealed Basis for Higher Infectivity.
    Khan A; Mohammad A; Haq I; Nasar M; Ahmad W; Yousafi Q; Suleman M; Ahmad S; Albutti A; Khan T; Marafie SK; Alshawaf E; Ali SS; Abubaker J; Wei DQ
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike - ACE2 complexes reveal distinct changes between both variants.
    Socher E; Heger L; Paulsen F; Zunke F; Arnold P
    Comput Struct Biotechnol J; 2022; 20():1168-1176. PubMed ID: 35251533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mutations modulating enhanced transmissibility of SARS-CoV-2 B.1.617+ (Delta) variant using In Silico tools.
    Shahhosseini N
    Gene Rep; 2022 Jun; 27():101636. PubMed ID: 35721780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense mutations in spike protein of SARS-CoV-2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor.
    Mahmood TB; Hossan MI; Mahmud S; Shimu MSS; Alam MJ; Bhuyan MMR; Emran TB
    Immun Inflamm Dis; 2022 Sep; 10(9):e683. PubMed ID: 36039645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.